Lung carcinomas decrease the number of monocytes/macrophages (CD14+ cells) that produce TNF-α

This publication has 27 references indexed in Scilit:

• Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
  European Journal Of Cancer, 2006
• Tumour necrosis factor-α as a tumour promoter
  European Journal Of Cancer, 2006
• NF-κB: linking inflammation and immunity to cancer development and progression
  Nature Reviews Immunology, 2005
• Inflammation-associated cancer: NF-κB is the lynchpin
  Trends in Immunology, 2005
• Anti-inflammatory Properties of the Novel Antitumor Agent Yondelis (Trabectedin): Inhibition of Macrophage Differentiation and Cytokine Production
  Cancer Research, 2005
• Vasoactive mediators (VEGF and TNF‐α) in patients with malignant and tuberculous pleural effusions
  Respirology, 2004
• Lack of correlation between growth inhibition by TGF-β and the percentage of cells expressing type II TGF-β receptor in human non-small cell lung carcinoma cell lines
  Lung Cancer, 2002
• Evasion mechanisms to tumor necrosis factor α (TNF-α) of small cell lung carcinoma and non-small cell lung carcinoma cell lines: comparison with the erythroleukaemia K-562 cell line
  Lung Cancer, 2000
• Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes
  Thorax, 1999
• Clinical applications of TNF-α in cancer
  Current Opinion in Immunology, 1998